Literature DB >> 18613369

Alcoholic diseases in hepato-gastroenterology: a point of view.

Gianni Testino1.   

Abstract

Alcohol damages every organ and system in the body. The most important effects from a clinical point of view relate to diseases of the circulatory, nervous and hepato-gastrointestinal systems. In the digestive tract the effects range from increased intestinal transit time and gastrophaties, leading to classical early morning nausea and diarrhea, through to significant malabsorption and chronic pancreatitis. In this review the mechanisms of alcoholic damage have been evaluated with particular reference to alcoholic liver disease (ALD). In particular, the natural history, the influence due to host genetic susceptibility and due to cofactors (i.e. hepatitis C virus), the clinical features and the hepatocarcinogenesis mechanisms have been evaluated. Finally, a possible role of abstinence in association with pharmacological therapy in the course of steatohepatitis has also been evaluated.

Entities:  

Mesh:

Year:  2008        PMID: 18613369

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  21 in total

1.  Copy number variations in 6q14.1 and 5q13.2 are associated with alcohol dependence.

Authors:  Peng Lin; Sarah M Hartz; Jen-Chyong Wang; Arpana Agrawal; Tian-Xiao Zhang; Nicholas McKenna; Kathleen Bucholz; Andrew I Brooks; Jay A Tischfield; Howard J Edenberg; Victor M Hesselbrock; John R Kramer; Samuel Kuperman; Marc A Schuckit; Alison M Goate; Laura J Bierut; John P Rice
Journal:  Alcohol Clin Exp Res       Date:  2012-06-15       Impact factor: 3.455

Review 2.  HIV, alcohol dependence, and the criminal justice system: a review and call for evidence-based treatment for released prisoners.

Authors:  Sandra A Springer; Marwan M Azar; Frederick L Altice
Journal:  Am J Drug Alcohol Abuse       Date:  2010-12-21       Impact factor: 3.829

Review 3.  Laboratory models available to study alcohol-induced organ damage and immune variations: choosing the appropriate model.

Authors:  Nympha B D'Souza El-Guindy; Elizabeth J Kovacs; Philippe De Witte; Claudia Spies; John M Littleton; Willem J S de Villiers; Amanda J Lott; Timothy P Plackett; Nadine Lanzke; Gary G Meadows
Journal:  Alcohol Clin Exp Res       Date:  2010-06-25       Impact factor: 3.455

4.  The burden of cancer attributable to alcohol consumption.

Authors:  Gianni Testino
Journal:  Maedica (Buchar)       Date:  2011-10

5.  Alcohol and gastrointestinal oncology.

Authors:  Gianni Testino; Paolo Borro
Journal:  World J Gastrointest Oncol       Date:  2010-08-15

6.  A meta-analysis of two genome-wide association studies to identify novel loci for maximum number of alcoholic drinks.

Authors:  Manav Kapoor; Jen-Chyong Wang; Leah Wetherill; Nhung Le; Sarah Bertelsen; Anthony L Hinrichs; John Budde; Arpana Agrawal; Kathleen Bucholz; Danielle Dick; Oscar Harari; Victor Hesselbrock; John Kramer; John I Nurnberger; John Rice; Nancy Saccone; Marc Schuckit; Jay Tischfield; Bernice Porjesz; Howard J Edenberg; Laura Bierut; Tatiana Foroud; Alison Goate
Journal:  Hum Genet       Date:  2013-06-07       Impact factor: 4.132

Review 7.  Acute alcoholic hepatitis, end stage alcoholic liver disease and liver transplantation: an Italian position statement.

Authors:  Gianni Testino; Patrizia Burra; Ferruccio Bonino; Francesco Piani; Alessandro Sumberaz; Roberto Peressutti; Andrea Giannelli Castiglione; Valentino Patussi; Tiziana Fanucchi; Ornella Ancarani; Giovanna De Cerce; Anna Teresa Iannini; Giovanni Greco; Antonio Mosti; Marilena Durante; Paola Babocci; Mariano Quartini; Davide Mioni; Sarino Aricò; Aniello Baselice; Silvia Leone; Fabiola Lozer; Emanuele Scafato; Paolo Borro
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

Review 8.  Alcohol and hepatocellular carcinoma: a review and a point of view.

Authors:  Gianni Testino; Silvia Leone; Paolo Borro
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

9.  Ethanol and its non-oxidative metabolites profoundly inhibit CFTR function in pancreatic epithelial cells which is prevented by ATP supplementation.

Authors:  L Judák; P Hegyi; Z Rakonczay; J Maléth; M A Gray; V Venglovecz
Journal:  Pflugers Arch       Date:  2013-08-16       Impact factor: 3.657

Review 10.  Nonalcoholic fatty liver disease and alcoholic liver disease: metabolic diseases with systemic manifestations.

Authors:  Alexander J Kovalic; George Cholankeril; Sanjaya K Satapathy
Journal:  Transl Gastroenterol Hepatol       Date:  2019-09-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.